Gacamide A
| Internal ID | 9311654b-9c3f-40dd-92e4-491bc24c772b |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | (3R)-4-[[(2R)-5-amino-1-[[(2S,3R)-1-[[(2R)-1-[[(2R)-5-amino-1-[[(3S,6R,9S,12S,15R)-3-[(2S)-butan-2-yl]-6-(hydroxymethyl)-9,12-bis(2-methylpropyl)-2,5,8,11,14-pentaoxo-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-[[(2R)-2-[[(3R)-3-hydroxydecanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C66H115N13O19/c1-14-17-18-19-20-21-40(81)30-52(84)69-43(26-34(4)5)58(89)74-47(31-53(85)86)62(93)71-42(23-25-51(68)83)57(88)78-54(38(12)15-2)65(96)75-46(29-37(10)11)59(90)70-41(22-24-50(67)82)56(87)77-49-33-98-66(97)55(39(13)16-3)79-63(94)48(32-80)76-61(92)45(28-36(8)9)72-60(91)44(27-35(6)7)73-64(49)95/h34-49,54-55,80-81H,14-33H2,1-13H3,(H2,67,82)(H2,68,83)(H,69,84)(H,70,90)(H,71,93)(H,72,91)(H,73,95)(H,74,89)(H,75,96)(H,76,92)(H,77,87)(H,78,88)(H,79,94)(H,85,86)/t38-,39+,40-,41-,42-,43-,44+,45+,46-,47-,48-,49-,54+,55+/m1/s1 |
| InChI Key | WTINGRXDSLFUKC-GGENCQROSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C66H115N13O19 |
| Molecular Weight | 1394.70 g/mol |
| Exact Mass | 1393.84321849 g/mol |
| Topological Polar Surface Area (TPSA) | 510.00 Ų |
| XlogP | 3.70 |
| Atomic LogP (AlogP) | -0.74 |
| H-Bond Acceptor | 18 |
| H-Bond Donor | 16 |
| Rotatable Bonds | 42 |
| CHEMBL4566332 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.5000 | 50.00% |
| Caco-2 | - | 0.8593 | 85.93% |
| Blood Brain Barrier | - | 0.9000 | 90.00% |
| Human oral bioavailability | - | 0.6571 | 65.71% |
| Subcellular localzation | Mitochondria | 0.4266 | 42.66% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8422 | 84.22% |
| OATP1B3 inhibitior | + | 0.9007 | 90.07% |
| MATE1 inhibitior | - | 0.9600 | 96.00% |
| OCT2 inhibitior | - | 0.9500 | 95.00% |
| BSEP inhibitior | + | 0.9584 | 95.84% |
| P-glycoprotein inhibitior | + | 0.7418 | 74.18% |
| P-glycoprotein substrate | + | 0.8824 | 88.24% |
| CYP3A4 substrate | + | 0.7139 | 71.39% |
| CYP2C9 substrate | - | 0.5936 | 59.36% |
| CYP2D6 substrate | - | 0.8651 | 86.51% |
| CYP3A4 inhibition | - | 0.7093 | 70.93% |
| CYP2C9 inhibition | - | 0.9428 | 94.28% |
| CYP2C19 inhibition | - | 0.9294 | 92.94% |
| CYP2D6 inhibition | - | 0.9240 | 92.40% |
| CYP1A2 inhibition | - | 0.9358 | 93.58% |
| CYP2C8 inhibition | + | 0.6815 | 68.15% |
| CYP inhibitory promiscuity | - | 0.9909 | 99.09% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8400 | 84.00% |
| Carcinogenicity (trinary) | Non-required | 0.6137 | 61.37% |
| Eye corrosion | - | 0.9848 | 98.48% |
| Eye irritation | - | 0.8957 | 89.57% |
| Skin irritation | - | 0.7880 | 78.80% |
| Skin corrosion | - | 0.9335 | 93.35% |
| Ames mutagenesis | - | 0.7837 | 78.37% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7083 | 70.83% |
| Micronuclear | + | 0.7800 | 78.00% |
| Hepatotoxicity | - | 0.5026 | 50.26% |
| skin sensitisation | - | 0.8728 | 87.28% |
| Respiratory toxicity | + | 0.6889 | 68.89% |
| Reproductive toxicity | + | 0.7444 | 74.44% |
| Mitochondrial toxicity | + | 0.7750 | 77.50% |
| Nephrotoxicity | + | 0.7353 | 73.53% |
| Acute Oral Toxicity (c) | III | 0.7165 | 71.65% |
| Estrogen receptor binding | + | 0.6701 | 67.01% |
| Androgen receptor binding | + | 0.7270 | 72.70% |
| Thyroid receptor binding | + | 0.5960 | 59.60% |
| Glucocorticoid receptor binding | + | 0.7244 | 72.44% |
| Aromatase binding | + | 0.7408 | 74.08% |
| PPAR gamma | + | 0.7656 | 76.56% |
| Honey bee toxicity | - | 0.7586 | 75.86% |
| Biodegradation | - | 0.7500 | 75.00% |
| Crustacea aquatic toxicity | + | 0.5396 | 53.96% |
| Fish aquatic toxicity | - | 0.5076 | 50.76% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.91% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.65% | 96.61% |
| CHEMBL4801 | P29466 | Caspase-1 | 98.52% | 96.85% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 98.33% | 94.45% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 97.86% | 99.17% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 97.64% | 93.56% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 97.55% | 95.00% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.46% | 96.09% |
| CHEMBL3776 | Q14790 | Caspase-8 | 97.21% | 97.06% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 96.53% | 97.23% |
| CHEMBL236 | P41143 | Delta opioid receptor | 96.51% | 99.35% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 95.83% | 91.11% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 95.83% | 97.09% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 94.99% | 96.11% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 94.98% | 96.47% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 93.93% | 88.42% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 93.74% | 98.03% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 93.70% | 98.94% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 93.49% | 98.05% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 93.07% | 94.66% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 92.95% | 90.24% |
| CHEMBL4769 | O95749 | Geranylgeranyl pyrophosphate synthetase | 92.82% | 92.08% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 92.77% | 96.00% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 92.12% | 100.00% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 92.11% | 92.32% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 91.68% | 97.29% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 91.47% | 94.45% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 91.41% | 100.00% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 91.30% | 96.90% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 90.87% | 89.50% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 90.82% | 90.71% |
| CHEMBL1801 | P00747 | Plasminogen | 90.55% | 92.44% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 90.43% | 91.81% |
| CHEMBL1907589 | P17787 | Neuronal acetylcholine receptor; alpha4/beta2 | 90.05% | 94.55% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 89.77% | 93.00% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 89.69% | 96.00% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 89.43% | 97.64% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 89.43% | 95.50% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 89.38% | 89.63% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 89.09% | 98.33% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 87.81% | 91.19% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 87.34% | 97.14% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 87.19% | 90.08% |
| CHEMBL2334 | P42574 | Caspase-3 | 86.99% | 98.25% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 86.50% | 97.25% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 86.31% | 83.82% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 86.13% | 100.00% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 86.10% | 97.50% |
| CHEMBL3468 | P55210 | Caspase-7 | 85.79% | 95.68% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 84.79% | 97.79% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 83.94% | 90.20% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 83.84% | 97.43% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 83.78% | 95.56% |
| CHEMBL2208 | P49137 | MAP kinase-activated protein kinase 2 | 83.61% | 95.20% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 83.56% | 93.18% |
| CHEMBL1781 | P11387 | DNA topoisomerase I | 83.47% | 97.00% |
| CHEMBL4662 | P28074 | Proteasome Macropain subunit MB1 | 83.12% | 93.85% |
| CHEMBL4374 | Q9Y5X4 | Photoreceptor-specific nuclear receptor | 82.46% | 85.00% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 82.44% | 96.33% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 82.15% | 94.75% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 81.90% | 95.38% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 81.74% | 100.00% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 81.41% | 89.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 145720798 |
| LOTUS | LTS0040731 |
| wikiData | Q105312564 |